{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "05/03/2018",
      "package_ndc": "65219-368-02",
      "generic_name": "Lorazepam Injection",
      "contact_info": "888-386-1300",
      "availability": "Unavailable",
      "related_info": "Next release September 2026. Check wholesalers for inventory.",
      "openfda": {
        "application_number": [
          "ANDA217598"
        ],
        "brand_name": [
          "LORAZEPAM"
        ],
        "generic_name": [
          "LORAZEPAM"
        ],
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC"
        ],
        "product_ndc": [
          "65219-368"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR",
          "INTRAVENOUS"
        ],
        "substance_name": [
          "LORAZEPAM"
        ],
        "rxcui": [
          "1665188"
        ],
        "spl_id": [
          "5cd2d0d8-9639-4e96-aafd-4991ad35fabc",
          "462a13da-259a-40e7-bd5b-f7f42ae025b7"
        ],
        "spl_set_id": [
          "b2487467-a63f-48b5-b0de-3a6ce6672d50",
          "462a13da-259a-40e7-bd5b-f7f42ae025b7"
        ],
        "package_ndc": [
          "65219-368-01",
          "65219-368-02",
          "65219-368-14",
          "65219-368-24"
        ],
        "nui": [
          "N0000175694",
          "M0002356"
        ],
        "pharm_class_epc": [
          "Benzodiazepine [EPC]"
        ],
        "pharm_class_cs": [
          "Benzodiazepines [CS]"
        ],
        "unii": [
          "O26FZP769L"
        ]
      },
      "update_date": "09/15/2026",
      "therapeutic_category": [
        "Neurology"
      ],
      "dosage_form": "Injection",
      "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)",
      "company_name": "Fresenius Kabi USA, LLC",
      "shortage_reason": "Demand increase for the drug",
      "status": "Current"
    }
  ]
}